Sylogist Ltd.
SYZLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11 | $16 | $16 | $15 |
| % Growth | -27.2% | -4% | 6.5% | – |
| Cost of Goods Sold | $6 | $7 | $7 | $6 |
| Gross Profit | $5 | $9 | $10 | $9 |
| % Margin | 44% | 57.7% | 59.1% | 58.9% |
| R&D Expenses | $1 | $2 | $2 | $1 |
| G&A Expenses | $3 | $4 | $3 | $2 |
| SG&A Expenses | $3 | $6 | $5 | $4 |
| Sales & Mktg Exp. | $2 | $2 | $2 | $2 |
| Other Operating Expenses | $0 | $3 | $3 | $0 |
| Operating Expenses | $5 | $10 | $10 | $5 |
| Operating Income | $0 | -$1 | -$0 | $1 |
| % Margin | 3% | -7.2% | -1.2% | 4.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$3 |
| Pre-Tax Income | -$0 | -$1 | -$1 | $1 |
| Tax Expense | $1 | $0 | $0 | -$0 |
| Net Income | -$1 | -$2 | -$1 | $1 |
| % Margin | -5.6% | -12.3% | -5.7% | 4.8% |
| EPS | -0.027 | -0.082 | -0.04 | 0.031 |
| % Growth | 66.8% | -105% | -227.4% | – |
| EPS Diluted | -0.027 | -0.082 | -0.04 | 0.03 |
| Weighted Avg Shares Out | 23 | 23 | 23 | 23 |
| Weighted Avg Shares Out Dil | 23 | 23 | 23 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $3 | $3 | $2 |
| EBITDA | $2 | $1 | $2 | $3 |
| % Margin | 17.7% | 9% | 14.8% | 16.6% |